These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 29718868

  • 1. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
    Zhang J, Jiang Y, Rui Q, Chen M, Zhang N, Yang H, Zhou Y.
    Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
    [Abstract] [Full Text] [Related]

  • 2. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.
    Am J Cardiol; 2011 Jul 15; 108(2):189-94. PubMed ID: 21545991
    [Abstract] [Full Text] [Related]

  • 3. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282
    [Abstract] [Full Text] [Related]

  • 4. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y, Hu S, Liu Y, Zhao R, Wang L, Fu G, He Q, Su X, Zheng Y, Qi X, Liu H, Wang J, Gao W, Wang M, Liu S, Zheng X, He B, Yang P, Zhou S, Gao C, Qiu C.
    EuroIntervention; 2012 Nov 22; 8(7):830-8. PubMed ID: 23045301
    [Abstract] [Full Text] [Related]

  • 5. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, Fernandes C, Jepson N, Leung DY.
    Intern Med J; 2009 Jan 22; 39(1):25-31. PubMed ID: 18771430
    [Abstract] [Full Text] [Related]

  • 6. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Iodixanol and Iopromide in Patients With Renal Insufficiency and Congestive Heart Failure Undergoing Coronary Angiography by Hemodynamic Monitoring.
    Qian G, Yang YQ, Dong W, Cao F, Chen YD.
    Angiology; 2017 Nov 01; 68(10):907-913. PubMed ID: 28401790
    [Abstract] [Full Text] [Related]

  • 8. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 9. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
    Hernández F, Mora L, García-Tejada J, Velázquez M, Gómez-Blázquez I, Bastante T, Albarrán A, Andreu J, Tascón J.
    Rev Esp Cardiol; 2009 Dec 05; 62(12):1373-80. PubMed ID: 20038403
    [Abstract] [Full Text] [Related]

  • 10. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, Costello P, Schoepf UJ.
    Radiology; 2008 Jul 05; 248(1):97-105. PubMed ID: 18483232
    [Abstract] [Full Text] [Related]

  • 11. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
    Lubbers MM, Kock M, Niezen A, Galema T, Kofflard M, Bruning T, Kooij HS, van Valen H, Dijkshoorn M, Booij R, Padmos A, Vogels A, Budde RPJ, Nieman K.
    Radiology; 2018 Jan 05; 286(1):71-80. PubMed ID: 28809582
    [Abstract] [Full Text] [Related]

  • 12. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS.
    Circ Cardiovasc Interv; 2010 Aug 05; 3(4):351-8. PubMed ID: 20647563
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
    Song T, Song M, Ge Z, Li Y, Shi P, Sun M.
    J Interv Cardiol; 2017 Jun 05; 30(3):281-285. PubMed ID: 28421628
    [Abstract] [Full Text] [Related]

  • 14. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T, Baumgart D, Elsner M, Herget-Rosenthal S, Pietruck F, Erbel R, Philipp T, Kribben A.
    Clin Nephrol; 2006 Nov 05; 66(5):322-30. PubMed ID: 17140161
    [Abstract] [Full Text] [Related]

  • 15. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC, Häberle L, Müller V, Bautz W, Uder M.
    Radiology; 2009 Jan 05; 250(1):68-86. PubMed ID: 19092091
    [Abstract] [Full Text] [Related]

  • 16. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators.
    N Engl J Med; 2003 Feb 06; 348(6):491-9. PubMed ID: 12571256
    [Abstract] [Full Text] [Related]

  • 17. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M, Radovic M, Kühnle Y, Combé V, Waigand J, Schröder S, Dietz R, Frei U, Eckardt KU.
    Nephrol Dial Transplant; 2008 May 06; 23(5):1588-94. PubMed ID: 18175785
    [Abstract] [Full Text] [Related]

  • 18. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I, Sperati F, Musicco F, Pozzi AF, di Turi A, Caterino M, de Lutio di Castelguidone E, Setola SV, Bellomi M, Neumaier CE, Conti L, Cigliana G, Merola R, Antenucci A, Orlandi G, Giordano A, Barba M, Canitano S.
    J Cell Physiol; 2018 Mar 06; 233(3):2572-2580. PubMed ID: 28777459
    [Abstract] [Full Text] [Related]

  • 19. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS.
    JACC Cardiovasc Interv; 2009 Jul 06; 2(7):645-54. PubMed ID: 19628188
    [Abstract] [Full Text] [Related]

  • 20. Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.
    Feng Y, Qiu G, Xu C, Duan Z, Wang M, Wang L, Hu W, Li P, Zhou H.
    J Healthc Eng; 2022 Jul 06; 2022():1469370. PubMed ID: 35422982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.